| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Aaron G.L. Fletcher | 10%+ Owner | $8.17M | Oct 4, 2024 | ||
| Leslie W. Kreis | 10%+ Owner | $8.17M | Oct 4, 2024 | ||
| William Tai-Wei Ho | PRESIDENT AND CEO, Director, 10%+ Owner | $2.4M | Feb 5, 2025 | ||
| Peter C. Brandt | Director | $351K | Dec 19, 2024 | ||
| Alan S. Roemer | Director | $151K | Dec 19, 2024 | ||
| Patrick McCall | Chief Financial Officer | $25.4K | Feb 5, 2025 | ||
| Kate Rochlin | Chief Operating Officer | $16.7K | Feb 5, 2025 | ||
| Trishna Goswami | Chief Medical Officer | $6.39K | Sep 4, 2024 | ||
| Emily Fairbairn | Director | Dec 19, 2024 | |||
| Jeremy R. Graff | Director | Dec 19, 2024 | |||
| Luba Greenwood | Director | Dec 19, 2024 | |||
| Lawrence Lamb | EVP and CSO | Feb 5, 2025 | |||
| Melissa Beelen | VP, Clinical Operation | Jul 29, 2021 | |||
| Bios Equity Partners, LP | 10%+ Owner | Aug 13, 2021 | |||
| Bios Clinical Opportunity Fund, LP | 10%+ Owner | Dec 13, 2023 | |||
| Corinne Epperly | Director | Dec 19, 2024 | |||
| Travis Whitfill | Director | Dec 19, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|